Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasm, Residual

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

194 public trials 80 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Not Yet Recruiting

Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients

NCT07247201

Conditions: Carcinoma, Head and Neck Neoplasms, Maximum Tolerated Dose, +19 more
Locations: Singapore General Hospital Singapore

View Trial Details

Not Yet Recruiting

Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia

NCT07483476

Conditions: Acute Lymphoblastic Leukemia ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

NCT07454486

Conditions: Adenocarcinoma, Biliary Tract Cancer (BTC), Biliary Tract Cancer (CCA), +28 more
Locations: Aarhus University Hospital Aarhus, Denmark

View Trial Details

Not Yet Recruiting

Treatment for Ph-negative ALL for Adults up to 65 Years

NCT07443592

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Hospital de A Coruña A Coruña, Spain

Hospital Universitario de Araba Alava, Spain

Hospital General Universitario de Albacete Albacete, Spain

Hospital General Universitario Dr. Balmis Alicante, Spain

View all 95 locations

View Trial Details

Not Yet Recruiting

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

NCT07413146

Conditions: Colon Cancer (Stage II &Amp; III), Colonic Diseases, Colonic Neoplasms, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

NCT07382505

Conditions: Cervical Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +16 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Not Yet Recruiting

Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC

NCT07350824

Conditions: Disease Attributes, HCC, Minimal Residual Disease, +6 more
Locations: Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

NCT07112612

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients

NCT07301138

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Automated vs Manual Flow-cytometry Gating for Measurable Residual Disease in Acute Myeloid Leukaemia (DUALFLOW)

NCT07269067

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +8 more
Locations: Not specified

View Trial Details